Itau Unibanco Holding S.A.’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100
Closed -$4.09K 454
2024
Q2
$4.09K Buy
+100
New +$4.16K ﹤0.01% 327
2024
Q1
Sell
-92
Closed -$3.9K 384
2023
Q4
$3.9K Sell
92
-6
-6% -$172 ﹤0.01% 354
2023
Q3
$2.14K Hold
98
﹤0.01% 464
2023
Q2
$3.12K Sell
98
-20
-17% -$614 ﹤0.01% 497
2023
Q1
$2.88K Hold
118
﹤0.01% 493
2022
Q4
$3.72K Sell
118
-3
-2% -$85 ﹤0.01% 493
2022
Q3
$3K Hold
121
﹤0.01% 526
2022
Q2
$3K Buy
+121
New +$3.44K ﹤0.01% 448

Other funds holding CERE

Itau Unibanco Holding S.A.'s CERE Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 100 shares — an estimated $4.09K sold.

Itau Unibanco Holding S.A. first reported a position in CERE in Q2 2022 and held it in 8 quarters. The position peaked at $4.09K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Itau Unibanco Holding S.A. reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 100 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $4.09K.
  • Itau Unibanco Holding S.A. first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Itau Unibanco Holding S.A.'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $4.09K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.